Inclusive of all taxes
Montelukast Sodium & Bambuterol Hydrochloride Tablets are a high-quality pharmaceutical formulation specifically designed for the management of respiratory ailments such as asthma and chronic obstructive pulmonary disease (COPD). This combination tablet delivers Montelukast, a leukotriene receptor antagonist that reduces airway inflammation, and Bambuterol Hydrochloride, a long-acting beta-2 agonist bronchodilator that relaxes airway muscles to improve breathing. Manufactured in WHO-GMP certified facilities by IndiGlobal Exports, these tablets meet stringent international export standards ensuring consistent dosage accuracy, therapeutic efficacy, and safety. The formulation is supplied in export-grade blister or strip packaging to preserve stability and guarantee product integrity during transit and storage. It is ideal for pharmaceutical distributors, hospitals, and healthcare institutions across global markets seeking quality-assured respiratory therapeutics. The product supports effective clinical management of persistent respiratory conditions by mitigating bronchospasm and airway inflammation, offering enhanced patient compliance through a convenient oral tablet format.
Key Features
| Features | Description |
|---|---|
| Active Ingredients | Montelukast Sodium and Bambuterol Hydrochloride |
| Indication | Management of respiratory conditions such as asthma and COPD |
| Dosage Form | Oral tablet |
| Manufacturing Standards | WHO-GMP compliant facilities |
| Packaging | Export-grade blister or strip packs |
| Therapeutic Action | Leukotriene receptor antagonist and long-acting beta-2 agonist bronchodilator |
| Compliance | Meets IP/USP pharmacopoeial quality standards |
| Target Market | International regulated and semi-regulated pharmaceutical markets |
| Shelf Life | As per regulatory standards |
| Manufacturer | IndiGlobal Exports |
| Attributes | Description |
|---|---|
| Category | Respiratory |
| Formulation | Tablet |
| Packaging Type | Blister or strip packs |
| Dosage Strength | Specific strength to be confirmed per batch (customizable) |
| Shelf Life | Compliant with regional regulatory requirements |
| Manufacturing Compliance | WHO-GMP certified |
| Pharmacopoeial Standards | IP/USP compliance |
| Intended Use | Therapeutic management of bronchoconstriction and airway inflammation |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Country of Origin | India |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
These tablets are specifically indicated for the management of bronchial asthma and chronic obstructive pulmonary disease (COPD), targeting airway inflammation and bronchospasm.
Yes, the tablets are manufactured in WHO-GMP compliant facilities and conform to IP/USP pharmacopoeial quality standards, ensuring suitability for global pharmaceutical markets.
The product is supplied in export-grade blister or strip packs, designed to maintain product stability and facilitate bulk shipping and storage.
While standard strengths are provided, manufacturers like IndiGlobal Exports may offer customization options on a per-batch basis depending on regulatory approval and buyer requirements.
Each batch undergoes rigorous quality control testing to verify dosage accuracy, efficacy, and safety, adhering to stringent export and pharmacopoeial guidelines.
Yes, the formulation and manufacturing processes comply with international standards, making it appropriate for both regulated and semi-regulated markets.
Brand: indiglobal exports
Country Of Origin: India
Montelukast Sodium & Bambuterol Hydrochloride Tablets is a pharmaceutical product indicated for respiratory treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations.
Features:Montelukast Sodium & Bambuterol Hydrochloride Tablets is developed for the effective management of respiratory conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.
This formulation supports the clinical treatment and ongoing care of patients with respiratory indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.
Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.
The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.
Inclusive of all taxes
You Save: 0
Panchkula , India
Service Provider , Professional Services, Exporter, Wholesaler
GST- 06eogps3248l1zf
